Natus Buys Grass Technologies for $18.6 Million

On Friday, infant-testing medical-equipment maker Natus Medical (NASDAQ: BABY  ) announced that it has acquired Astro-Med (NASDAQ: ALOT  ) subsidiary and neurophysiological recording instruments manufacturer Grass Technologies Product Group. Grass specializes in the production of polysomnography and electroencephalography systems used in both clinical and research work.

In a press release on the acquisition, Natus clarified that it paid $18.6 million cash for Grass, or almost precisely the company's annual sales of $18.5 million. That represents a sizable discount to the 1.4 sales ratio Natus' own shares fetch.

Natus expects the acquisition to quickly become accretive on a pro forma basis, adding to earnings in both Q2 and full-year 2013.

Investors reacted positively to the news, bidding Natus shares up 1.8% Friday to close at $12.54.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2231953, ~/Articles/ArticleHandler.aspx, 4/24/2014 4:35:13 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement